ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1037

Develop an in Vitro Model to Test the Different Behavior of mtDNA in OA and Healthy Patients, Based on Mitochondrial Activity and Metabolic Response

Mercedes Fernandez Moreno1, Andrea Dalamao-Fernandez2, Tamara Hermida-Gómez3, Jenny Lund4, Arild Rustan4, Maria Eugenia Vazquez Mosquera5, Sara Relaño-Fernandez6, Ignacio Rego-Pérez5 and Francisco J Blanco7, 1Servicio de Reumatología. Area Genomica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), Spain. CIBER-BBN, Madrid, Spain, 2Servicio de Reumatología. Area Genomica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A CORUÑA, Spain, 3Rheumatology, INIBIC. Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. CIBER-BBN., A Coruña, Spain, 4Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Norway, Oslo, Norway, 5Servicio de Reumatología. Area Genomica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 6Plataforma de Genómica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain, 7Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo HospitalarioUniversitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Metabolism, mitochondria and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Osteoarthritis and Joint Biology – Basic Science Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Mitochondrial dysfunction is well documented in OA and has the capacity to alter chondrocyte function and viability, contributing to cartilage degeneration. Several studies have showed that chondrocytes from OA patients have mitochondrial alterations. With this background, it is important can evaluate the influence of mitochondria in the pathogenesis of OA using an in vitro model to explain the functional consequences of this association and help us to identify potential diagnostic biomarkers and/or therapeutic targets. Transmitochondrial cybrids are a useful cellular model to study the mitochondrial role in the cellular behavior, since they carry different mitochondrial variants with the same nuclear background. The aim of this work is used an in vitro model based in cybrids with mtDNA from healthy and OA donors and characterize them. Comparing the data with data obtained from human articular chondrocytes.

Methods: mtDNA Cybrids were developed using 143B.TK–Rho-0 cell as nuclear donor, and platelets from patients N and OA. Human articular chondrocytes were obtained from patients with hip replacement. The mtDNA copy number was measured by real-time PCR method. The O2– production was evaluated using flow cytometry. The glucose oxidation assay was measured using D-[14C(U)]glucose during 4 h CO2 trapping. The glycolytic activity was measure after addition of glucose, oligomycin and 2-dioxyglucose using Seahorse XFp (ECAR). The OXPHOS function was evaluated by SeaHorse XFp (OCR) after addition of oligomycin, FCCP and Rotenone/Antimycin. Appropriate statistical analyses were performed with GraphPad Prism v6.

Results: mtDNA copy number showed that OA have higher levels than N in cybrids and human chondrocytes showed the same results. The analysis of O2– production showed that OA had higher levels than N in both types of cells. The metabolic status analyzing glucose oxidation and total glucose cellular uptake reflected higher values in OA cybrids than N cybrids. But the analysis of glycolysis showed lower values in OA than N cybrids. The analysis of OXPHOS function showed that OA had lower basal respiration and maximal respiratory capacity than N in both types of cells.

Conclusion: In this study, we showed that OA cybrids behave differently from cybrids from healthy (N) donors, while they have a similar behavior to OA and N articular chondrocytes. This information enhances our understanding of the role of mitochondria in OA and suggests that cybrids are a possible model for the study of OA pathogenesis. All these data support that N cybrids and chondrocytes use mitochondria with more efficiency.


Disclosure: M. Fernandez Moreno, None; A. Dalamao-Fernandez, None; T. Hermida-Gómez, None; J. Lund, None; A. Rustan, None; M. E. Vazquez Mosquera, None; S. Relaño-Fernandez, None; I. Rego-Pérez, None; F. J. Blanco, None.

To cite this abstract in AMA style:

Fernandez Moreno M, Dalamao-Fernandez A, Hermida-Gómez T, Lund J, Rustan A, Vazquez Mosquera ME, Relaño-Fernandez S, Rego-Pérez I, Blanco FJ. Develop an in Vitro Model to Test the Different Behavior of mtDNA in OA and Healthy Patients, Based on Mitochondrial Activity and Metabolic Response [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/develop-an-in-vitro-model-to-test-the-different-behavior-of-mtdna-in-oa-and-healthy-patients-based-on-mitochondrial-activity-and-metabolic-response/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/develop-an-in-vitro-model-to-test-the-different-behavior-of-mtdna-in-oa-and-healthy-patients-based-on-mitochondrial-activity-and-metabolic-response/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology